Additionally, elevated levels of dipeptidyl peptidase-4 (DPP-4) have been identified in individuals with FPLD, suggesting that DPP-4 inhibitors may be a relevant therapeutic option for managing diabetes in these patients [74]. The gene discussed is DPP4; the disease is diabetes mellitus.